Dr. Martens (LSE:DOCS) Market Cap: £671.9 Mil (As of Jun. 25, 2026)


LSE:DOCS Dr. Martens PLC LSE:DOCS
52 GF Score
Price £0.70
GF Value £0.72
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens Market Cap?

Dr. Martens LSE:DOCS +1.30% 52 Market Cap is £671.9 Mil as of Jun. 25, 2026. GuruFocus rates LSE:DOCS with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,087 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks better than 89.88% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Dr. Martens's share price for the quarter that ended in Mar. 2026 was £0.6295. Dr. Martens's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 956.6 Mil. Therefore, Dr. Martens's market cap for the quarter that ended in Mar. 2026 was £602.2 Mil.

Dr. Martens's quarterly market cap increased from Mar. 2025 (£491.1 Mil) to Sep. 2025 (£959.4 Mil) but then declined from Sep. 2025 (£959.4 Mil) to Mar. 2026 (£602.2 Mil).

Dr. Martens's annual market cap declined from Mar. 2024 (£843.7 Mil) to Mar. 2025 (£491.1 Mil) but then increased from Mar. 2025 (£491.1 Mil) to Mar. 2026 (£602.2 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dr. Martens's Enterprise Value for Today is £885.1 Mil.


Dr. Martens  (LSE:DOCS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Dr. Martens Market Cap Related Terms


Dr. Martens Market Cap Historical Data

* Premium members only.

The historical data trend for Dr. Martens's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens Market Cap Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Market Cap
Get a 7-Day Free Trial Premium Member Only 2,388.49 1,423.97 843.70 491.06 602.19

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 843.70 541.41 491.06 959.40 602.19

LSE:DOCS vs NKE, DECK, ONON: Market Cap Comparison

For the Footwear & Accessories subindustry, Dr. Martens's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Martens Market Cap vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Market Cap distribution charts can be found below:

* The bar in red indicates where Dr. Martens's Market Cap falls into.


LSE:DOCS
52GF Score
Dr. Martens PLC LSE:DOCS
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Dr. Martens's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as

Market Cap (A: Mar. 2026 )=Share Price (A: Mar. 2026 )*Shares Outstanding (EOP) (A: Mar. 2026 )
=£0.6295*956.616
=£602.2

Dr. Martens's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=£0.6295*956.616
=£602.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of £671.9 Mil mean?
Dr. Martens (LSE:DOCS) has a Market Cap of £671.9 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dr. Martens and its competitors. According to the industry distribution chart, Dr. Martens ranks #110 out of 1087 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 10.1%.
Is Dr. Martens' Market Cap too high?
Dr. Martens' current Market Cap is £671.9 Mil. Based on the distribution chart, Dr. Martens ranks #110 out of 1087 companies in the Manufacturing - Apparel & Accessories industry, which is in the top quartile — a strong position relative to peers. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Market Cap compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #110 out of 1087 companies for Market Cap. This places Dr. Martens in the top 10% of its industry — outperforming the majority of peers. The industry median Market Cap is 44.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Manufacturing - Apparel & Accessories company?
The median Market Cap among Manufacturing - Apparel & Accessories companies is 44.91, based on 1,087 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Market Cap is 44.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Market Cap is £671.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (LSE:DOCS) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.70 — trading 2.5% below its estimated fair value. The current Market Cap is £671.9 Mil. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Dr. Martens (LSE:DOCS), the current Market Cap is £671.9 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (LSE:DOCS) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued. The current stock price of £0.70 is trading 2.5% below its estimated GF Value™ of £0.72. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for LSE:DOCS:

  • Market Cap: £671.9 Mil
  • GF Value™: £0.72 vs. price of £0.70 (2.5% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the LSE:DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score

Get the complete analysis for LSE:DOCS

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.70
Price
£0.72
GF Value